Results 211 to 220 of about 966,959 (266)
Probabilistic clustering using shared latent variable model for assessing Alzheimer's disease biomarkers. [PDF]
BiostatisticsXu Y, Zeger S, Wang Z.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Biomarkers for neurodegenerative diseases
Nature Medicine, 2021Biomarkers for neurodegenerative diseases are needed to improve the diagnostic workup in the clinic but also to facilitate the development and monitoring of effective disease-modifying therapies. Positron emission tomography methods detecting amyloid-β and tau pathology in Alzheimer's disease have been increasingly used to improve the design of ...
KEON MATT, SAKSENA NITIN, BRENNAN SAM
openaire +6 more sources
Biomarkers in Parkinson’s Disease
Current Neurology and Neuroscience Reports, 2010Biomarkers are objectively measured characteristics that are indicators of normal biological processes, pathogenic processes, or responses to therapeutic interventions. To date, clinical assessment remains the gold standard in the diagnosis of Parkinson's disease (PD) and clinical rating scales are well established as the gold standard for tracking ...
John C, Morgan +2 more
openaire +2 more sources